IP Library Granted Patent US 12,049,566
Granted Patent B2
US 12,049,566 · App. 16/320,343 · Granted Jul 30, 2024

Method for preserving leuco chromogen-containing aqueous solution

Inventors: Haruyo Soya (Sunto-gun, JP); Yuki Katayama (Sunto-gun, JP)
Assignee: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
C09B67/0017C09B21/00C09B67/00C09B67/0083C12Q1/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,049,566
App. No.
16/320,343
Granted
Jul 30, 2024
Kind
B2
Abstract

The present invention provides a method for preserving a leuco chromogen-containing aqueous solution comprising: adding at least one acid compound selected from the group consisting of a phosphoric acid compound, a carboxylic acid compound, a sulfonic acid compound, and a sulfuric acid compound to a leuco chromogen-containing aqueous solution; a method for stabilizing a leuco chromogen in an aqueous solution comprising: adding at least one acid compound selected from the group consisting of a phosphoric acid compound, a carboxylic acid compound, a sulfonic acid compound, and a sulfuric acid compound to a leuco chromogen-containing aqueous solution; and a liquid reagent comprising a leuco chromogen and at least one acid compound selected from the group consisting of a phosphoric acid compound, a carboxylic acid compound, a sulfonic acid compound, and a sulfuric acid compound.

Claims (32)

1. A method for preserving a leuco chromogen-containing aqueous solution comprising:

adding at least one acid compound selected from the group consisting of a first compound, a second compound, a third compound, and a fourth compound to the leuco chromogen-containing aqueous solution,

wherein the first compound is selected from the group consisting of alkyl phosphoric acid, polyoxyethylene alkyl ether phosphoric acid, polyoxyethylene polycyclic phenyl ether phosphoric acid, and salts thereof,

wherein the second compound is selected from the group consisting of polyoxyethylene alkyl ether fatty acid, N-acylamino acid in which a hydrogen atom of the amino group may be substituted with a substituent, and salts thereof,

wherein the third compound is selected from the group consisting of N-acyl taurine in which a hydrogen atom of the amino group may be substituted with a substituent, α-olefin sulfonic acid, alkyl sulfocarboxylic acid, polyoxymethylene alkyl sulfocarboxylic acid, and salts thereof,

wherein the fourth compound is selected from the group consisting of alkyl sulfuric acid, polyoxyethylene alkyl ether sulfuric acid, and salts thereof, and

wherein the leuco chromogen comprises a phenothiazine chromogen.

2. The method according to claim 1 , wherein the phenothiazine chromogen comprises 10-(carboxymethylaminocarbonyl)-3, 7-bis(dimethylamino)phenothiazine or a salt thereof.

3. A method for stabilizing a leuco chromogen in an aqueous solution comprising:

adding at least one acid compound selected from the group consisting of a first compound, a second compound, a third compound, and a fourth compound to a leuco chromogen-containing aqueous solution,

wherein the first compound is selected from the group consisting of alkyl phosphoric acid, polyoxyethylene alkyl ether phosphoric acid, polyoxyethylene polycyclic phenyl ether phosphoric acid, and salts thereof,

wherein the second compound is selected from the group consisting of polyoxyethylene alkyl ether fatty acid, N-acylamino acid in which a hydrogen atom of the amino group may be substituted with a substituent, and salts thereof,

wherein the third compound is selected from the group consisting of N-acyl taurine in which a hydrogen atom of the amino group may be substituted with a substituent, α-olefin sulfonic acid, alkyl sulfocarboxylic acid, polyoxymethylene alkyl sulfocarboxylic acid, and salts thereof,

wherein the fourth compound is selected from the group consisting of alkyl sulfuric acid, polyoxyethylene alkyl ether sulfuric acid, and salts thereof, and

wherein the leuco chromogen comprises a phenothiazine chromogen.

4. The method according to claim 3 , wherein the phenothiazine chromogen comprises 10-(carboxymethylaminocarbonyI)-3, 7-bis(dimethylamino)phenothiazine or a salt thereof.

5. The method according to claim 1 , wherein the first compound is selected from the group consisting of sodium lauryl phosphate, polyoxyethylene tridecyl ether phosphoric acid, polyoxyethylene octyl ether phosphoric acid, polyoxyethylene lauryl ether phosphoric acid, polyoxyethylene lauryl ether phosphate-monoethanolamine salt, and polyoxyethylene styrenated phenyl ether phosphoric acid.

6. The method according to claim 1 , wherein the second compound is selected from the group consisting of sodium polyoxyethylene lauryl ether acetate, polyoxyethylene lauryl ether acetic acid, sodium polyoxyethylene tridecyl ether acetate, N-lauroyl-N-methyl-β-alanine sodium, N-palmitoyl sarcosine sodium, sodium N-lauroyl sarcosine, N-myristoyl sarcosine sodium, and N-oleoyl sarcosine.

7. The method according to claim 1 , wherein the third compound is selected from the group consisting of N-lauroyl-N-methyl taurine sodium, N-palmitoyl-N-methyl taurine sodium, N-myristoyl-N-methyl taurine sodium, N-stearoyl-N-methyl taurine sodium; α-olefin sulfonic acid, sodium lauryl sulfoacetate, sodium dioctyl sulfosuccinate, lauryl polyoxyethylene sulfosuccinate disodium, sodium lauryl sulfosuccinate, and alkyl polyoxyethylene sulfosuccinate disodium.

8. The method according to claim 1 , wherein the fourth compound is sodium lauryl sulfate or sodium polyoxyethylene lauryl ether sulfate.

9. The method according to claim 1 , wherein the leuco chromogen-containing aqueous solution comprises from 0.0001 mmol/L to 2.0 mmol/L of the leuco chromogen.

10. The method according to claim 3 , wherein the first compound is selected from the group consisting of sodium lauryl phosphate, polyoxyethylene tridecyl ether phosphoric acid, polyoxyethylene octyl ether phosphoric acid, polyoxyethylene lauryl ether phosphoric acid, polyoxyethylene lauryl ether phosphate-monoethanolamine salt, and polyoxyethylene styrenated phenyl ether phosphoric acid.

11. The method according to claim 3 , wherein the second compound is selected from the group consisting of sodium polyoxyethylene lauryl ether acetate, polyoxyethylene lauryl ether acetic acid, sodium polyoxyethylene tridecyl ether acetate, N-lauroyl-N-methyl-β-alanine sodium, N-palmitoyl sarcosine sodium, sodium N-lauroyl sarcosine, N-myristoyl sarcosine sodium, and N-oleoyl sarcosine.

12. The method according to claim 3 , wherein the third compound is selected from the group consisting of N-lauroyl-N-methyl taurine sodium, N-palmitoyl-N-methyl taurine sodium, N-myristoyl-N-methyl taurine sodium, N-stearoyl-N-methyl taurine sodium; α-olefin sulfonic acid, sodium lauryl sulfoacetate, sodium dioctyl sulfosuccinate, lauryl polyoxyethylene sulfosuccinate disodium, sodium lauryl sulfosuccinate, and alkyl polyoxyethylene sulfosuccinate disodium.

13. The method according to claim 3 , wherein the fourth compound is sodium lauryl sulfate or sodium polyoxyethylene lauryl ether sulfate.

14. The method according to claim 1 , wherein the method comprises adding the first compound to the leuco chromogen-containing aqueous solution.

15. The method according to claim 1 , wherein the method comprises adding the second compound to the leuco chromogen-containing aqueous solution.

16. The method according to claim 1 , wherein the method comprises adding the third compound to the leuco chromogen-containing aqueous solution.

17. The method according to claim 1 , wherein the method comprises adding the fourth compound to the leuco chromogen-containing aqueous solution.

18. The method according to claim 3 , wherein the method comprises adding the first compound to the leuco chromogen-containing aqueous solution.

19. The method according to claim 3 , wherein the method comprises adding the second compound to the leuco chromogen-containing aqueous solution.

20. The method according to claim 3 , wherein the method comprises adding the third compound to the leuco chromogen-containing aqueous solution.

Assignments (5)
CHANGE OF NAME Recorded Sep 23, 2025
From: KYOWA MEDEX CO., LTD.
To: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
Reel/Frame 072925/0508 →
CHANGE OF NAME Recorded Sep 23, 2025
From: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
To: MINARIS MEDICAL CO., LTD.
Reel/Frame 072925/0657 →
CHANGE OF NAME Recorded Sep 23, 2025
From: MINARIS MEDICAL CO., LTD.
To: CANON MEDICAL DIAGNOSTICS CORPORATION
Reel/Frame 072925/0690 →
CHANGE OF NAME Recorded Aug 29, 2019
From: KYOWA MEDEX CO., LTD.
To: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
Reel/Frame 050209/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2019
From: SOYA, HARUYO; KATAYAMA, YUKI
To: KYOWA MEDEX CO., LTD.
Reel/Frame 048526/0664 →
Priority Claims (1)
JP 2016-150499 · Jul 29, 2016 · national
Continuity (1)
Related Publication 20190177548A1 · Jun 13, 2019